Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$47K Buy
636
+223
+54% +$16.9K 0.04% 205
2020
Q4
$30K Sell
413
-2,098
-84% -$148K 0.03% 261
2020
Q3
$167K Sell
2,511
-8
-0.3% -$506 0.01% 312
2020
Q2
$143K Sell
2,519
-57
-2% -$2.8K 0.02% 371
2020
Q1
$90K Sell
2,576
-28
-1% -$1.33K 0.02% 365
2019
Q4
$136K Buy
2,604
+1,788
+219% +$89K 0.04% 296
2019
Q3
$41K Sell
816
-15
-2% -$738 0.01% 612
2019
Q2
$40K Buy
831
+333
+67% +$15.4K 0.01% 612
2019
Q1
$24K Sell
498
-26
-5% -$1.17K 0.01% 273
2018
Q4
$22K Buy
524
+12
+2% +$492 0.01% 249
2018
Q3
$21K Buy
512
+82
+19% +$3.31K 0.01% 216
2018
Q2
$17K Buy
+430
New +$16.5K 0.01% 231

Other funds holding HOLX

CSat Investment Advisory's HOLX Position: Q1 2021 in Review

CSat Investment Advisory increased its Hologic (HOLX) stake by 54% in Q1 2021, buying an estimated $16.9K and bringing the position to 636 shares worth $47K. The position accounts for 0.04% of the portfolio, ranked #205.

CSat Investment Advisory first reported a position in HOLX in Q2 2018 and has held it in 12 quarters since. The position peaked at $167K in Q3 2020. 638 funds tracked by Wall St. Rank hold HOLX as of Q1 2021.

  • CSat Investment Advisory held 636 shares of Hologic worth $47K as of Q1 2021.
  • CSat Investment Advisory bought 223 Hologic shares in Q1 2021, an estimated $16.9K.
  • Hologic made up 0.04% of CSat Investment Advisory's portfolio in Q1 2021, its #205 holding.
  • CSat Investment Advisory first reported a position in Hologic in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Hologic position peaked at $167K in Q3 2020.
  • 638 funds tracked by Wall St. Rank held Hologic as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.